RxDoctor Payments Data

Kayla Fowler, PA

Medical · Altoona, PANPI 1457779910

Payments from drug & device makers

$1,967in general payments, 2019–2025

Across 15 payments — averaging $131.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pulmonx Corporation$2K
  • Boston Scientific$114
  • Harmony Biosciences LLC$55
  • Axsome Therapeutics, Inc.$50
  • Philips North America LLC$19
  • GSK$19
  • plus $36 from 2 others

What the payments were for

  • Travel & lodging$1,40972%
  • Food & beverage$54027%
  • Education$181%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,967 in reported general payments places this provider in the 75th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$14,677
Medicare patients
158
Services billed
217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter936$628,108
Breo ElliptaFluticasone/Vilanterol388$158,698
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr69$31,119
Spiriva RespimatTiotropium Bromide40$30,489
Fluticasone-SalmeterolFluticasone Propion/Salmeterol140$18,588
Advair HfaFluticasone Propion/Salmeterol39$12,320
Albuterol Sulfate HfaAlbuterol Sulfate278$9,654
Arnuity ElliptaFluticasone Furoate42$9,537
EliquisApixaban14$8,183
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate39$7,367
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,887
Varenicline Tartrate25$6,805
Ventolin HfaAlbuterol Sulfate98$6,585
Qvar RedihalerBeclomethasone Dipropionate16$4,952
BreynaBudesonide/Formoterol Fumarate14$3,175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta$19$827,4621,435 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Altoona

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →